Robert Davies analyst MORGAN STANLEY

Currently out of the existing stock ratings of Robert Davies, 6 are a HOLD (85.71%), 1 are a BUY (14.29%).

Robert Davies

Work Performance Price Targets & Ratings Chart

Analyst Robert Davies works at MORGAN STANLEY with a stock forecast success ratio of 33.33% fulfilled within 14.33 days on average.

Robert Davies’s has documented 18 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on FMS, Fresenius Medical Care at 20-Oct-2023.

Wall Street Analyst Robert Davies

Analyst best performing recommendations are on PHG (KONINKLIJKE PHILIPS NV ADR).
The best stock recommendation documented was for PHG (KONINKLIJKE PHILIPS NV ADR) at 1/17/2023. The price target of $17.38 was fulfilled within 16 days with a profit of $1.41 (8.83%) receiving and performance score of 5.52.

Average potential price target upside

FMS Fresenius Medical Care PHG Koninklijke Philips NV ADR SNN Smith & Nephew SNATS

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

34

5 months 4 days ago

0/2 (0%)

$15.46 (83.39%)

36.47

$15.71 (75.67%)

50.57

5 months 19 days ago

4/15 (26.67%)

$19.39 (113.52%)

137

Sell

29.84

$9.08 (43.74%)

33.99

5 months 25 days ago

3/15 (20%)

$12.41 (71.20%)

116

40.12

$19.36 (93.26%)

44.25

6 months 8 days ago

0/5 (0%)

$22.47 (127.31%)

Hold

24

$3.24 (15.61%)

28

6 months 17 days ago

4/9 (44.44%)

$6.73 (38.97%)

153

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Robert Davies?

On 2022

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?